These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 301402)

  • 1. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H; Mikami S; Okuda T; Murashima N; Takase T
    Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR
    J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
    Moake JL; Weinstein MJ; Troll JH; Chute LE; Colannino NM
    Blood; 1983 Jun; 61(6):1163-73. PubMed ID: 6404328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.
    Sodetz JM; Paulson JC; Pizzo SV; McKee PA
    J Biol Chem; 1978 Oct; 253(20):7202-6. PubMed ID: 100492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of factor VIII/von Willebrand Factor.
    Meyer D; McKee PA; Hoyer LW; Zimmerman TS; Gralnick HR
    Thromb Haemost; 1978 Oct; 40(2):245-51. PubMed ID: 310584
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR; Coller BS; Sultan Y
    Science; 1976 Apr; 192(4234):56-9. PubMed ID: 1083071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von Willebrand's disease and cryosupernatant prepared from normal plasma.
    Pietu G; Obert B; Larrieu MJ; Meyer D
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):671-85. PubMed ID: 6777898
    [No Abstract]   [Full Text] [Related]  

  • 10. The factor VIII complex: structure and function.
    Hoyer LW
    Blood; 1981 Jul; 58(1):1-13. PubMed ID: 6165414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective binding of the factor VIII/von Willebrand factor protein to human platelets.
    Morisato DK; Gralnick HR
    Blood; 1980 Jan; 55(1):9-15. PubMed ID: 6965350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 17. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens.
    Lazarchick J; Pappas AA; Kizer J; Hall SA
    Am J Hematol; 1986 Mar; 21(3):305-14. PubMed ID: 3080872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure and function of the factor VIII/von Willebrand factor complex].
    Müller G
    Z Gesamte Inn Med; 1990 Mar; 45(3):65-8. PubMed ID: 2159676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.